Global Parkinson's Disease Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application

SKU ID :QYR-14047211 | Published Date: 29-May-2019 | No. of pages: 104
Table of Contents Parkinson's Disease Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025 1 Industry Overview of Parkinson's Disease Therapeutics 1.1 Parkinson's Disease Therapeutics Market Overview 1.1.1 Parkinson's Disease Therapeutics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Parkinson's Disease Therapeutics Market Size and Analysis by Regions 1.2.1 North America 1.2.2 Europe 1.2.3 China 1.2.4 Rest of Asia Pacific 1.2.5 Central & South America 1.2.6 Middle East & Africa 1.3 Parkinson's Disease Therapeutics Market by Type 1.3.1 Medications Therapeutics 1.3.2 Medical Devices Therapeutics 1.4 Parkinson's Disease Therapeutics Market by End Users/Application 1.4.1 Under 40 Years Old 1.4.2 40-65 Years Old 1.4.3 Above 65 Years Old 2 Global Parkinson's Disease Therapeutics Competition Analysis by Players 2.1 Parkinson's Disease Therapeutics Market Size (Value) by Players (2018 and 2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 GSK 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019) 3.1.5 Recent Developments 3.2 Novartis 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019) 3.2.5 Recent Developments 3.3 Boehringer Ingelheim 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019) 3.3.5 Recent Developments 3.4 Teva Pharmaceutical 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019) 3.4.5 Recent Developments 3.5 Abbvie 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019) 3.5.5 Recent Developments 3.6 Merck 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019) 3.6.5 Recent Developments 3.7 Akorn 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019) 3.7.5 Recent Developments 3.8 Kyowa Hakko Kirin Pharma 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019) 3.8.5 Recent Developments 3.9 Astellas Pharma 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019) 3.9.5 Recent Developments 3.10 Desitin Arzneimittel 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019) 3.10.5 Recent Developments 3.11 Endo Pharmaceuticals 3.12 F.Hoffmann-La Roche 3.13 H.Lundbeck 3.14 Valeant 3.15 Apokyn 3.16 Orion 3.17 Stada Arzneimittel 3.18 US WorldMeds 3.19 Valeant Pharmaceuticals 4 Global Parkinson's Disease Therapeutics Market Size by Type and Application (2014-2019) 4.1 Global Parkinson's Disease Therapeutics Market Size by Type (2014-2019) 4.2 Global Parkinson's Disease Therapeutics Market Size by Application (2014-2019) 4.3 Potential Application of Parkinson's Disease Therapeutics in Future 4.4 Top Consumer/End Users of Parkinson's Disease Therapeutics 5 North America Parkinson's Disease Therapeutics Development Status and Outlook 5.1 North America Parkinson's Disease Therapeutics Market Size (2014-2019) 5.2 North America Parkinson's Disease Therapeutics Market Size and Market Share by Players (2018 and 2019) 6 Europe Parkinson's Disease Therapeutics Development Status and Outlook 6.1 Europe Parkinson's Disease Therapeutics Market Size (2014-2019) 6.2 Europe Parkinson's Disease Therapeutics Market Size and Market Share by Players (2018 and 2019) 7 China Parkinson's Disease Therapeutics Development Status and Outlook 7.1 China Parkinson's Disease Therapeutics Market Size (2014-2019) 7.2 China Parkinson's Disease Therapeutics Market Size and Market Share by Players (2018 and 2019) 8 Rest of Asia Pacific Parkinson's Disease Therapeutics Development Status and Outlook 8.1 Rest of Asia Pacific Parkinson's Disease Therapeutics Market Size (2014-2019) 8.2 Rest of Asia Pacific Parkinson's Disease Therapeutics Market Size and Market Share by Players (2018 and 2019) 9 Central & South America Parkinson's Disease Therapeutics Development Status and Outlook 9.1 Central & South America Parkinson's Disease Therapeutics Market Size (2014-2019) 9.2 Central & South America Parkinson's Disease Therapeutics Market Size and Market Share by Players (2018 and 2019) 10 Middle East & Africa Parkinson's Disease Therapeutics Development Status and Outlook 10.1 Middle East & Africa Parkinson's Disease Therapeutics Market Size (2014-2019) 10.2 Middle East & Africa Parkinson's Disease Therapeutics Market Size and Market Share by Players (2018 and 2019) 11 Market Forecast by Regions, Type and Application (2019-2025) 11.1 Global Parkinson's Disease Therapeutics Market Size (Value) by Regions (2019-2025) 11.1.1 North America Parkinson's Disease Therapeutics Revenue and Growth Rate (2019-2025) 11.1.2 Europe Parkinson's Disease Therapeutics Revenue and Growth Rate (2019-2025) 11.1.3 China Parkinson's Disease Therapeutics Revenue and Growth Rate (2019-2025) 11.1.4 Rest of Asia Pacific Parkinson's Disease Therapeutics Revenue and Growth Rate (2019-2025) 11.1.5 Central & South America Parkinson's Disease Therapeutics Revenue and Growth Rate (2019-2025) 11.1.6 Middle East & Africa Parkinson's Disease Therapeutics Revenue and Growth Rate (2019-2025) 11.2 Global Parkinson's Disease Therapeutics Market Size (Value) by Type (2019-2025) 11.3 Global Parkinson's Disease Therapeutics Market Size by Application (2019-2025) 12 Parkinson's Disease Therapeutics Market Dynamics 12.1 Parkinson's Disease Therapeutics Market Opportunities 12.2 Parkinson's Disease Therapeutics Challenge and Risk 12.2.1 Competition from Opponents 12.2.2 Downside Risks of Economy 12.3 Parkinson's Disease Therapeutics Market Constraints and Threat 12.3.1 Threat from Substitute 12.3.2 Government Policy 12.3.3 Technology Risks 12.4 Parkinson's Disease Therapeutics Market Driving Force 12.4.1 Growing Demand from Emerging Markets 12.4.2 Potential Application 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs Trend/Customer Preference 13.3 External Environmental Change 13.3.1 Economic Fluctuations 13.3.2 Other Risk Factors 14 Research Finding/Conclusion 15 Appendix Methodology Analyst Introduction Data Source
List of Tables and Figures Figure Parkinson's Disease Therapeutics Product Scope Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) (2014-2019) Table Global Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Global Parkinson's Disease Therapeutics Market Share by Regions in 2018 Figure North America Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Europe Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure China Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Rest of Asia Pacific Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Central & South America Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Middle East & Africa Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Global Parkinson's Disease Therapeutics Market Share by Type in 2018 Figure Medications Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Medical Devices Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Global Parkinson's Disease Therapeutics Market Share by Application in 2018 Table Key Downstream Customer in Under 40 Years Old Figure Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate in Under 40 Years Old (2014-2019) Table Key Downstream Customer in 40-65 Years Old Figure Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate in 40-65 Years Old (2014-2019) Table Key Downstream Customer in Above 65 Years Old Figure Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate in Above 65 Years Old (2014-2019) Table Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2018 and 2019) Figure Parkinson's Disease Therapeutics Market Size Share by Players in 2018 Figure Parkinson's Disease Therapeutics Market Size Share by Players in 2019 Table GSK Basic Information List Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of GSK (2014-2019) Figure GSK Parkinson's Disease Therapeutics Business Revenue Market Share in 2018 Table Novartis Basic Information List Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Novartis (2014-2019) Figure Novartis Parkinson's Disease Therapeutics Business Revenue Market Share in 2018 Table Boehringer Ingelheim Basic Information List Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Boehringer Ingelheim (2014-2019) Figure Boehringer Ingelheim Parkinson's Disease Therapeutics Business Revenue Market Share in 2018 Table Teva Pharmaceutical Basic Information List Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Teva Pharmaceutical (2014-2019) Figure Teva Pharmaceutical Parkinson's Disease Therapeutics Business Revenue Market Share in 2018 Table Abbvie Basic Information List Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Abbvie (2014-2019) Figure Abbvie Parkinson's Disease Therapeutics Business Revenue Market Share in 2018 Table Merck Basic Information List Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Merck (2014-2019) Figure Merck Parkinson's Disease Therapeutics Business Revenue Market Share in 2018 Table Akorn Basic Information List Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Akorn (2014-2019) Figure Akorn Parkinson's Disease Therapeutics Business Revenue Market Share in 2018 Table Kyowa Hakko Kirin Pharma Basic Information List Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Kyowa Hakko Kirin Pharma (2014-2019) Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Business Revenue Market Share in 2018 Table Astellas Pharma Basic Information List Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Astellas Pharma (2014-2019) Figure Astellas Pharma Parkinson's Disease Therapeutics Business Revenue Market Share in 20187 Table Desitin Arzneimittel Basic Information List Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Desitin Arzneimittel (2014-2019) Figure Desitin Arzneimittel Parkinson's Disease Therapeutics Business Revenue Market Share in 2018 Table Endo Pharmaceuticals Basic Information List Table F.Hoffmann-La Roche Basic Information List Table H.Lundbeck Basic Information List Table Valeant Basic Information List Table Apokyn Basic Information List Table Orion Basic Information List Table Stada Arzneimittel Basic Information List Table US WorldMeds Basic Information List Table Valeant Pharmaceuticals Basic Information List Table Global Parkinson's Disease Therapeutics Market Size (Million USD) by Type (2014-2019) Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2014 Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2015 Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2016 Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2017 Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2018 Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2019 Table Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application (2014-2019) Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2014 Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2015 Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2015 Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2017 Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2018 Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2019 Table Top Consumer/End Users of Parkinson's Disease Therapeutics Figure North America Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table North America Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2014-2019) Figure North America Parkinson's Disease Therapeutics Market Size Share by Players in 2018 Figure North America Parkinson's Disease Therapeutics Market Size Share by Players in 2019 Figure Europe Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Europe Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2014-2019) Figure Europe Parkinson's Disease Therapeutics Market Size Share by Players in 2018 Figure Europe Parkinson's Disease Therapeutics Market Size Share by Players in 2019 Figure China Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table China Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2014-2019) Figure China Parkinson's Disease Therapeutics Market Size Share by Players in 2018 Figure China Parkinson's Disease Therapeutics Market Size Share by Players in 2019 Figure Rest of Asia Pacific Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Rest of Asia Pacific Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2014-2019) Figure Rest of Asia Pacific Parkinson's Disease Therapeutics Market Size Share by Players in 2018 Figure Rest of Asia Pacific Parkinson's Disease Therapeutics Market Size Share by Players in 2019 Figure Central & South America Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Central & South America Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2014-2019) Figure Central & South America Parkinson's Disease Therapeutics Market Size Share by Players in 2018 Figure Central & South America Parkinson's Disease Therapeutics Market Size Share by Players in 2019 Figure Middle East & Africa Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Middle East & Africa Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2014-2019) Figure Middle East & Africa Parkinson's Disease Therapeutics Market Size Share by Players in 2018 Figure Middle East & Africa Parkinson's Disease Therapeutics Market Size Share by Players in 2019 Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Regions (2019-2025) Table Global Parkinson's Disease Therapeutics Market Size (Million USD) by Regions (2019-2025) Figure Global Parkinson's Disease Therapeutics Market Size Share by Regions in 2019 Figure Global Parkinson's Disease Therapeutics Market Size Share by Regions in 2025 Figure North America Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Europe Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure China Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Rest of Asia Pacific Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Central & South America Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Middle East & Africa Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Table Global Parkinson's Disease Therapeutics Market Size (Million USD) by Type (2019-2025) Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2019 Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2025 Table Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application (2019-2025) Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2019 Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2025
GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie Merck Akorn Kyowa Hakko Kirin Pharma Astellas Pharma Desitin Arzneimittel Endo Pharmaceuticals F.Hoffmann-La Roche H.Lundbeck Valeant Apokyn Orion Stada Arzneimittel US WorldMeds Valeant Pharmaceuticals
  • PRICE
  • $3350
    $6700

Our Clients